Loading clinical trials...

Effect of GaAlAs 940 Laser on Pain and Wound Healing After Free Gingival Graft | Clinical Trials | Clareo Health

COMPLETEDNA

Effect of GaAlAs 940 Laser on Pain and Wound Healing After Free Gingival Graft

Biomodulatory Effects of GaAlAs 940 nm on Pain Control and Wound Healing at Palatal Donor Site Following Free Gingival Graft Harvesting: a Randomized Controlled Clinical Trial

NCT07308912•University of Medicine and Pharmacy at Ho Chi Minh City

View on ClinicalTrials.gov

Summary

This randomized controlled clinical trial aims to evaluate the biomodulatory effects of a 940-nm GaAlAs diode laser on postoperative pain control and wound healing at the palatal donor site following free gingival graft harvesting. Adult patients undergoing free gingival graft surgery will be randomly allocated to receive either a single session of adjunctive diode laser irradiation immediately after surgery or conventional postoperative care alone. Postoperative pain will be assessed using a visual analog scale, while clinical parameters related to wound healing, including bleeding tendency, epithelialization, and wound size reduction, will be evaluated at predefined follow-up time points. The findings of this study may contribute to the clinical understanding of photobiomodulation in free gingival graft surgery.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. ≥18 years of age;
•2. systemically healthy individuals without any conditions that could affect wound healing (e.g., diabetes, immunosuppression, coagulation disorders, Candida infection;
•3. full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) \<15%;
•4. no previous history of palatal tissue harvesting;
•5. no use of overdentures or partial dentures covering the donor area.

Exclusion Criteria

•1. pregnant or breastfeeding women;
•2. smokers;
•3. patients with psychiatric disorders; and
•4. patients taking any medications that impair tissue healing and affect pain perception.

Locations (1)

Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City

Ho Chi Minh City, Vietnam

Key Dates

Start Date

October 1, 2024

Primary Completion Date

October 1, 2025

Completion Date

October 1, 2025

Last Updated

December 30, 2025

Enrollment

ACTUAL participants

Conditions

Low Level Laser TherapyHealthyPostoperative Pain ManagementWound Healing

Interventions

940 nm GaAlAs diode laser

DEVICE

palatal stent

DEVICE

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

NCT07310264

Healthy Volunteers (HV)Parkinson's Disease (PD)

View study

RECRUITINGPHASE1/PHASE2

Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.

NCT06290258

Autism Spectrum DisorderGastrointestinal Diseases+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 30, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of GaAlAs 940 Laser on Pain and Wound Healing After Free Gingival Graft

Inclusion Criteria

Exclusion Criteria

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.

Collection of Data and Samples From Healthy Donors for Use in Translational Research

A New Portable Device for Non-invasive Ventilatory Support

Turkish Validity and Reliability Study of PRevention of Toxic Chemicals in the Environment for Children Tool

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases